BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 18, 2025
Product Development

2025 catalysts: New modality showdowns 

Genetic therapies compete in the same indications, as degraders come of age
BioCentury | Jul 26, 2012
Distillery Therapeutics

Indication: Neurology

BioCentury | Jul 5, 2010
Emerging Company Profile

ProNoxis: Promoting ROS

ProNoxis hopes reactive oxygen species provide a benefit in rheumatoid arthritis
BioCentury | Dec 9, 2002
Company News

Arexis other research news

Items per page:
1 - 4 of 4
Help Center
Username
Request a Demo
Request Training
Ask a Question